Literature DB >> 9176799

IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment.

K al Ghamdi1, O Ghaffar, P Small, S Frenkiel, Q Hamid.   

Abstract

OBJECTIVE: Chronic sinusitis with allergy (ACS) and without allergy (NCS) are inflammatory diseases with considerable morbidity. The present study was undertaken to investigate, by in situ hybridization, the expression of IL-13 and IL-4 mRNA in sinus biopsy sections.
METHOD: Specimens were obtained from subjects with NCS (n = 12), ACS (n = 13), ACS on steroid therapy (n = 11), and normal controls (n = 11). The composition of the inflammatory infiltrate was also examined in all cases.
RESULTS: The number of cells expressing IL-4 and IL-13 transcripts was significantly higher in subjects with ACS compared to normal controls. In contrast, the numbers of IL-13 but not IL-4 mRNA-positive cells were increased in the NCS subjects compared to the normal controls. IL-4 and IL-13 mRNA expression was suppressed in ACS subjects on topical steroid therapy compared to untreated patients. There was no significant difference in the numbers of eosinophils between the ACS subjects treated with steroids and those who were not treated, but the steroid-treated patients demonstrated significantly higher numbers of CD8+ cells in the sinus mucosa. Increased numbers of CD8+ cells were also observed in subjects with NCS compared with ACS subjects and normal controls.
CONCLUSIONS: These results demonstrate that increased IL-13 expression is an important feature of allergic and nonallergic patients with chronic sinusitis. Furthermore, our data indicate that IL-13 and IL-4 are under differential regulation in NCS subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176799

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  13 in total

Review 1.  Chronic rhinosinusitis and sleep: a contemporary review.

Authors:  Jeremiah A Alt; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2013-08-26       Impact factor: 3.858

2.  Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: a pilot study.

Authors:  Jeremiah A Alt; Nathan B Sautter; Jess C Mace; Kara Y Detwiller; Timothy L Smith
Journal:  Laryngoscope       Date:  2013-10-22       Impact factor: 3.325

Review 3.  [Asthma, allergic rhinitis, sinusitis. Concept of the "unified respiratory tracts"].

Authors:  J C Virchow
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

Review 4.  The role of ubiquitous airborne fungi in chronic rhinosinusitis.

Authors:  Jens U Ponikau; David A Sherris; Gail M Kephart; Cheryl Adolphson; Hirohito Kita
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 5.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

Review 6.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

7.  Effect of endoscopic sinus surgery on asthmatic patients with chronic rhinosinusitis.

Authors:  Satish Nair; Rajbala S Bhadauria; Sanjeevan Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-10-12

8.  IL-33-activated dendritic cells induce an atypical TH2-type response.

Authors:  Matthew A Rank; Takao Kobayashi; Hideaki Kozaki; Kathleen R Bartemes; Diane L Squillace; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2009-04-10       Impact factor: 10.793

9.  Sinonasal epithelial wound resealing in an in vitro model: inhibition of wound closure with IL-4 exposure.

Authors:  Sarah K Wise; Kyle A Den Beste; Elizabeth K Hoddeson; Charles A Parkos; Asma Nusrat
Journal:  Int Forum Allergy Rhinol       Date:  2013-03-06       Impact factor: 3.858

Review 10.  Molecular immunology and immunotherapy for chronic sinusitis.

Authors:  Lily H P Nguyen; Samer Fakhri; Saul Frenkiel; Qutayba A Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.